Lysosomal cathepsin leakage as a tunable rheostat linking oxidative stress to kin-selected senescence

Hypothesis

Progressive lysosomal cathepsin leakage is not merely a passive consequence of oxidative damage; it functions as a tunable rheostat that couples cellular stress levels to the intensity of senescence-associated secretory phenotype (SASP) output, thereby modulating resource allocation between self-maintenance and kin support. In this view, the decline of cystatin B and the rise of cytosolic cathepsin L activity are regulated, at least in part, by nutrient‑sensing pathways (e.g., mTORC1) that adjust the proteolytic tone of lysosomes in response to energetic cues. When nutrients are abundant, mTORC1 activity suppresses cystatin B transcription, permitting modest cathepsin L‑mediated histone H3 tail cleavage that promotes a low‑grade SASP favoring tissue repair and mild paracrine senescence. Under caloric restriction or oxidative stress, reduced mTORC1 signaling lifts this suppression, increasing cystatin B levels to curb cathepsin leakage and limit SASP, thereby preserving cellular homeostasis for the individual. Conversely, when an organism approaches the end of its reproductive window, a programmed decline in cystatin B expression—driven by age‑associated epigenetic shifts—allows cathepsin leakage to rise, amplifying SASP and accelerating the removal of aged individuals to free resources for kin. This mechanism converts stochastic lysosomal damage into a phenotypically plastic signal that can be selected for its group‑level benefits while still appearing as damage accumulation at the molecular level.

Testable Predictions

• Prediction 1: Tissue‑specific overexpression of cystatin B in aged mice will attenuate cathepsin L‑dependent histone H3 cleavage and reduce SASP markers (IL‑6, CCL2) without altering baseline lysosomal pH or oxidative load. If the rheostat model is correct, lifespan extension will be accompanied by a measurable decrease in kin‑directed resource sharing behaviors (e.g., reduced pup survival in communal nesting assays).
• Prediction 2: Pharmacological inhibition of mTORC1 (rapamycin) in young animals will increase cystatin B expression, lower cytosolic cathepsin L activity, and shift SASP toward an anti‑inflammatory profile. Conversely, mTORC1 activation (via MHY1485) in mid‑life mice should reproduce the age‑associated cystatin B decline and enhance cathepsin leakage, accelerating senescence markers.
• Prediction 3: In vitro cultures of human fibroblasts exposed to graded H2O2 will show a biphasic response: low oxidative stress increases cystatin B via AMPK activation and reduces cathepsin leakage, whereas high stress overwhelms this response, leading to uncontrolled LMP. Measuring cathepsin activity in the cytosol versus lysosome will reveal a switch point that correlates with mTORC1 activity readouts (p‑S6K).
• Prediction 4: Comparative transcriptomic analysis of cystatin B promoter regions across mammals with differing eusocial tendencies will reveal conserved binding sites for FOXO and NF‑Y factors that are modulated by reproductive status, supporting a link between cystatin B regulation and life‑history strategies.

Experimental Approach

1. Generate a Cre‑inducible cystatin B overexpression allele (Rosa26‑LSL‑CSTB) and cross with tissue‑specific promoters (e.g., CamKIIα for neurons, Alb for liver). Treat cohorts with either ad libitum diet or 30% caloric restriction, monitor lysosomal integrity (galectin‑3 puncta), cathepsin activity (fluorogenic substrates), SASP cytokines (Luminex), and survival.
2. Apply rapamycin or MHY1485 to wild‑type mice at 6 months of age, assess cystatin B levels by Western blot, cathepsin L cytosolic fractionation, and histone H3 cleavage (H3K4me3 loss) via immunofluorescence.
3. Treat primary human fibroblasts with a H2O2 gradient (0‑200 µM), measure cystatin B mRNA (qPCR), phospho‑AMPK and phospho‑S6K (Western), and subcellular cathepsin distribution (subcellular fractionation + activity assay).
4. Perform ATAC‑seq and ChIP‑seq for FOXO1/3 and NF‑Y on cystatin B promoter loci from liver samples of young vs. old mice and from eusocial (naked mole‑rat) vs. solitary species.

Falsifiability

If cystatin B manipulation fails to alter cytosolic cathepsin L activity or SASP composition, or if changes in cystatin B do not correlate with shifts in kin‑directed fitness proxies (e.g., offspring survival under resource limitation), the rheostat hypothesis would be refuted. Likewise, a lack of nutrient‑sensing pathway influence on cystatin B expression would undermine the proposed regulatory link, reinforcing the view that cathepsin leakage is purely damage‑driven without adaptive tunability.